Qualifying Conditions Of Medical Cannabis License Holders In The United States

被引:152
作者
Boehnke, Kevin F. [1 ]
Gangopadhyay, Saurav [2 ]
Clauw, Daniel J. [3 ]
Haffajee, Rebecca L. [4 ]
机构
[1] Univ Michigan, Anesthesiol, Ann Arbor, MI 48109 USA
[2] Deloitte, Chicago, IL USA
[3] Univ Michigan, Med Sch, Anesthesiol Med & Psychiat, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Publ Hlth, Hlth Management & Policy, Ann Arbor, MI 48109 USA
关键词
MARIJUANA LAWS; PAIN; SUBSTITUTION; ACCESS; DRUGS;
D O I
10.1377/hlthaff.2018.05266
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The evidence for cannabis's treatment efficacy across different conditions varies widely, and comprehensive data on the conditions for which people use cannabis are lacking. We analyzed state registry data to provide nationwide estimates characterizing the qualifying conditions for which patients are licensed to use cannabis medically. We also compared the prevalence of medical cannabis qualifying conditions to recent evidence from the National Academies of Sciences, Engineering, and Medicine report on cannabis's efficacy in treating each condition. Twenty states and the District of Columbia had available registry data on patient numbers, and fifteen states had data on patient-reported qualifying conditions. Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (64.9 percent in 2016). Of all patient-reported qualifying conditions, 85.5 percent had either substantial or conclusive evidence of therapeutic efficacy. As medical cannabis use continues to increase, creating a nationwide patient registry would facilitate better understanding of trends in use and of its potential effectiveness.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 32 条
[1]   Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly [J].
Abuhasira, Ran ;
Schleider, Lihi Bar-Lev ;
Mechoulam, Raphael ;
Novack, Victor .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 49 :44-50
[2]  
[Anonymous], 33 LEG MED MAR STAT
[3]   Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 [J].
Bachhuber, Marcus A. ;
Saloner, Brendan ;
Cunningham, Chinazo O. ;
Barry, Colleen L. .
JAMA INTERNAL MEDICINE, 2014, 174 (10) :1668-1673
[4]   Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain [J].
Boehnke, Kevin F. ;
Litinas, Evangelos ;
Clauw, Daniel J. .
JOURNAL OF PAIN, 2016, 17 (06) :739-744
[5]   Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population [J].
Bradford, Ashley C. ;
Bradford, W. David ;
Abraham, Amanda ;
Adams, Grace Bagwell .
JAMA INTERNAL MEDICINE, 2018, 178 (05) :667-672
[6]   Medical Marijuana Laws May Be Associated With A Decline In The Number Of Prescriptions For Medicaid Enrollees [J].
Bradford, Ashley C. ;
Bradford, W. David .
HEALTH AFFAIRS, 2017, 36 (05) :945-951
[7]   Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D [J].
Bradford, Ashley C. ;
Bradford, W. David .
HEALTH AFFAIRS, 2016, 35 (07) :1230-1236
[8]  
Chesler J, 2015, US TODAY
[9]   PAIN MANAGEMENT Fibromyalgia drugs are 'as good as it gets' in chronic pain [J].
Clauw, Daniel J. .
NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (08) :439-440
[10]   Cannabis as a substitute for prescription drugs - a cross-sectional study [J].
Corroon, James M., Jr. ;
Mischley, Laurie K. ;
Sexton, Michelle .
JOURNAL OF PAIN RESEARCH, 2017, 10 :989-997